BT-70 Fully Automated Blood Grouping System

BT-70 Fully Automated Blood Grouping System

Other
BT-70 Fully Automated Blood Grouping System
BT-70 Fully Automated Blood Grouping System

Information

The BT-70 is an automated immunohematology analysis system developed by Medcaptain. lt utilizes8-column agglutination technology (CAT) Gel cards to streamline blood typing and compatibility testing in modern blood bank laboratories. With its advanced features and automation, the BT-70 system enhances transfusion safety and meets the evolving needs of blood banks worldwide. Main features ` Diverse testing menu, including antibody identification & titration, Weak D, among other specialized tests ` Flexible and open management for red blood cells (RBCs) and quality control (OC) reagents ` Real-time resource usage monitoring and enables true walk-away operation ` Supports variable speed centrifugation for adaptable processing ` Two robotic pipetting arms with disposable tips, effectively reducing cross-contamination and minimizing maintenance work ` Double-sided high-definition colour photo interpretation of gel cards for accurate analysis BT Gel Cards 8-column agglutination technology (CAT) for Immunohematology Perfectly works with · Fully automated analyzer: Medcaptain BT-70 · Semi-automated solution: Medcaptain BT FYQ Incubator and BT TXK4 Centrifuge
Medcaptain Medical Technology Co LtdZ2.J50Founded in 2011, Medcaptain Medical Technology Co., Ltd. is dedicated to pursuing innovation in 5 key fields: Medication Delivery, Minimally Invasive Interventions, Anesthesia & Respiratory, In-Vitro Diagnostics, and Medical Disposables. Medcaptain shares a global vision and aims to be captain in the medical device industry. As a globally recognized brand in the field of medication delivery, Medcaptain has introduced patented technologies that have successfully covered existing gaps in the medical device industry. In the field of In-Vitro Diagnostics, Medcaptain’s products range from coagulation, chemiluminescence, to molecular diagnosis and other tests. In addition, we have introduced the world's first fully automated haemostasis analysis system, and provide a complete COVID-19 diagnostic solution which includes rapid virus detection, nucleic acid detection and neutralizing antibody test that reflect changes in antibody levels after vaccination. After the outbreak of the novel coronavirus epidemic, Medcaptain’s high-end infusion workstations, video laryngoscopes, nutrition pumps and COVID-19 diagnostic solutions have helped many countries and regions cope with the challenges of the pandemic. Furthermore, Medcaptain has donated 15 million Yuan worth of medical equipment in China and abroad as our contribution to the global fight against the pandemic. At present, Medcaptain’s products are being used in over 100 countries around the world. We have set up offices in the Netherlands, Colombia, Turkey, India and Thailand. By continuously improving our existing solutions and introducing innovative technologies, Medcaptain is relentlessly contributing to improving the quality of healthcare on a global level.

Join the event!